Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 101 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. The company provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The firm markets its corporate drug testing services through its own sales force, distributors, and partners. The company markets its home drug testing service, PDT-90, through the Internet.
Follow-Up Questions
Who is the CEO of Psychemedics Corp?
Mr. Brian Hullinger is the President of Psychemedics Corp, joining the firm since 2023.
What is the price performance of PMDI stock?
The current price of PMDI is $2.11, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Psychemedics Corp?
Psychemedics Corp belongs to Health Care industry and the sector is Health Care
